在慢性骨髓单细胞白血病中RAS路径突变的风景和临床病理特征
Guillermo Montalban-Bravo1, Sanam Loghavi2, Ziyi Li3
1The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Blood advances
|July 11, 2025
概括
在慢性骨髓单细胞白血病 (CMML) 中,RAS通路突变 (RASMT) 是常见的. 这些突变会影响患者的存活率和疾病的进展,突显了针对性治疗的必要性.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 遗传学是一种遗传学.
背景情况:
- RAS通路突变 (RASMT) 驱动慢性骨髓单细胞白血病 (CMML) 的扩散和转变.
- 在CMML中,不同RASMT的克隆架构和层次结构尚不清楚.
研究的目的:
- 在大型CMML队列中描述RASMT的景观,架构和临床影响.
- 探索不同RASMT的共同发生模式和预后意义.
主要方法:
- 对814名CMML患者队列的分析.
- 识别和描述RASMT,包括它们的克隆主导和共变模式.
- 评估RASMT对整体存活率和无白血病存活率 (LFS) 的影响.
主要成果:
- 在42%的患者中发现了RASMT,N/KRAS和CBL突变是最常见的,经常占主导地位.
- BRAF,NF1和PTPN11突变经常是亚克隆的.
- CBL突变与SRSF2和TET2突变同时发生,而PTPN11突变与SETBP1和DNMT3A.A.相关.
- RASMT与较短的整体存活率和LFS有关,并影响了特定CMML亚型的结果.
结论:
- 在CMML的发病和预后中,RASMT发挥着重要作用.
- 特定的RASMT表现出不同的克隆行为和共同突变配置文件.
- 这些发现支持CMML精细的基因组分类,并倡导RAS导向疗法.
相关概念视频
The Ras Gene
6.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.4K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Small GTPases - Ras and Rho
4.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.2K
MAPK Signaling Cascades
6.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.1K
The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K


